Alpha Cognition (ACOGF) News Today → Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (From Banyan Hill Publishing) (Ad) Free ACOGF Stock Alerts C$0.50 -0.01 (-1.96%) (As of 05/14/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 14 at 7:24 PM | businesswire.comAlpha Cognition Announces First Quarter of 2024 Results and Provides Corporate UpdateApril 3, 2024 | businesswire.comAlpha Cognition Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate UpdateApril 2, 2024 | finance.yahoo.comPresenting on the Emerging Growth Conference 69 Day 1 on April 3 Register NowMarch 20, 2024 | businesswire.comAlpha Cognition to Present at the Emerging Growth Conference on April 3, 2024 at 12:00pm EDT.March 5, 2024 | finance.yahoo.comLife Science Virtual Investor Forum Agenda Announced for March 7th, 2024March 1, 2024 | finance.yahoo.comAlpha Cognition to Present at the Life Science Investor Forum March 7thFebruary 22, 2024 | businesswire.comAlpha Cognition Files U.S. Patent Application Covering an ALPHA-1062 Oral Formulation to Treat Mild to Moderate Alzheimer's DiseaseFebruary 12, 2024 | finance.yahoo.comAlpha Cognition Provides Business UpdateFebruary 6, 2024 | finance.yahoo.comACOGF: Obtaining CapitalFebruary 6, 2024 | finance.yahoo.comACOGF: Full Year 2022 Financial ReportDecember 29, 2023 | nasdaq.comAlpha Cognition Inc (ACOGF)December 22, 2023 | finance.yahoo.comAlpha Cognition Announces Fourth Closing of Private Placement and Continuation of the OfferingDecember 8, 2023 | msn.comFDA accepts Alpha Cognition’s NDA for Alzheimer’s diseaseDecember 7, 2023 | stockhouse.comAlpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer's DiseaseDecember 7, 2023 | finance.yahoo.comAlpha Cognition Announces FDA Acceptance of New Drug Application for ALPHA-1062 for Mild-to-Moderate Alzheimer’s DiseaseDecember 4, 2023 | finance.yahoo.comAlpha Cognition Announces Amended Terms of Private Placement and Continuation of the OfferingNovember 14, 2023 | morningstar.comAlpha Cognition Inc Ordinary Shares ACOGFNovember 8, 2023 | finance.yahoo.comAlpha Cognition Announces Third Closing of Private Placement and Continuation of the OfferingOctober 2, 2023 | finance.yahoo.comCanadian Investment Regulatory Organization Trading Halt - ACOG.WTSeptember 27, 2023 | finance.yahoo.comAlpha Cognition Announces Submission of New Drug Application to the FDA for ALPHA-1062 for Mild-to-Moderate Alzheimer’s DiseaseSeptember 20, 2023 | forbes.comWolfram Alpha, Meet ChatGPT: Stephen Wolfram Talks Intelligence And Large Language ModelsAugust 31, 2023 | finance.yahoo.comAlpha Cognition Announces Initial Closing of Private Placement and Pricing for Continuation of the OfferingAugust 22, 2023 | msn.comAlpha Cognition GAAP EPS of -$0.03August 22, 2023 | finance.yahoo.comAlpha Cognition Announces Second Quarter and Six Months Ended 2023 Results and Provides Corporate UpdateAugust 14, 2023 | finance.yahoo.comAlpha Cognition Receives Notice of Allowance for U.S. Patent Application covering use of ALPHA-1062 for Mild to Moderate Alzheimer’s DiseaseAugust 11, 2023 | finance.yahoo.comACOGF - Alpha Cognition Inc.October 18, 2022 | finance.yahoo.comACOGF: Bioequivalence Complete Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOGF and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016. Get the full story here. ACOGF Media Mentions By Week ACOGF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACOGF News Sentiment▼0.000.55▲Average Medical News Sentiment ACOGF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACOGF Articles This Week▼10▲ACOGF Articles Average Week Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOGF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Celularity News Augmedix News Enzo Biochem News InspireMD News Prenetics Global News Checkpoint Therapeutics News Immix Biopharma News Hyperfine News Kezar Life Sciences News Eledon Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:ACOGF) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
